Inflammation  >>  NNC 0151-0000-0000  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NNC 0151-0000-0000 / Novo Nordisk
NCT01223911 / 2009-011791-30: A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Completed
2
34
Europe
NNC 0151-0000-0000, placebo
Novo Nordisk A/S
Inflammation, Rheumatoid Arthritis
02/13
02/13

Download Options